Sorbello A - Search Results

1

A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.

Ren YR, Golding A, Sorbello A, Ji P, Chen J, Saluja B, Witzmann K, Arya V, Reynolds KS, Choi SY, Nikolov NP, Sahajwalla C. Ren YR, et al. Among authors: sorbello a. J Clin Pharmacol. 2020 Aug;60(8):954-975. doi: 10.1002/jcph.1673. Epub 2020 Jun 24. J Clin Pharmacol. 2020. PMID: 32469437 Free PMC article. Review.

2

Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.

Sorbello A, Jones SC, Carter W, Struble K, Boucher R, Truffa M, Birnkrant D, Gada N, Camilli S, Chan I, Dallas S, Scales T, Kosko R, Thompson E, Goodman J, Francis H, Dal Pan G. Sorbello A, et al. Clin Infect Dis. 2012 Jul;55(1):1-7. doi: 10.1093/cid/cis351. Epub 2012 Apr 5. Clin Infect Dis. 2012. PMID: 22491501

3

Current advances in pharmacovigilance in the USA and Europe: meeting the challenges of safety monitoring in HIV.

Marcus KA, Sorbello A, Truffa M, Williams J, Raine JM, Powderly WG. Marcus KA, et al. Among authors: sorbello a. Curr Opin HIV AIDS. 2012 Jul;7(4):292-8. doi: 10.1097/COH.0b013e328354dcac. Curr Opin HIV AIDS. 2012. PMID: 22647589 Review.

4

Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.

Sorbello A, Komo S, Valappil T, Nambiar S. Sorbello A, et al. Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S36-41. doi: 10.1086/653038. Clin Infect Dis. 2010. PMID: 20597669 Review.

5

Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients.

Fine AJ, Sorbello A, Kortepeter C, Scarazzini L. Fine AJ, et al. Among authors: sorbello a. Clin Infect Dis. 2013 Sep;57(6):849-52. doi: 10.1093/cid/cit376. Epub 2013 May 31. Clin Infect Dis. 2013. PMID: 23728144

6

Harnessing scientific literature reports for pharmacovigilance. Prototype software analytical tool development and usability testing.

Sorbello A, Ripple A, Tonning J, Munoz M, Hasan R, Ly T, Francis H, Bodenreider O. Sorbello A, et al. Appl Clin Inform. 2017 Mar 22;8(1):291-305. doi: 10.4338/ACI-2016-11-RA-0188. Appl Clin Inform. 2017. PMID: 28326432 Free PMC article.

7

Who gets treated for influenza: A surveillance study from the US Food and Drug Administration's Sentinel System.

Cocoros NM, Haug N, Cosgrove A, Panozzo CA, Sorbello A, Francis H, Garcia C, Orr R, Toh S, Dutcher SK, Measer GT. Cocoros NM, et al. Among authors: sorbello a. Infect Control Hosp Epidemiol. 2022 Sep;43(9):1228-1234. doi: 10.1017/ice.2021.311. Epub 2021 Aug 5. Infect Control Hosp Epidemiol. 2022. PMID: 34350819

8

Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.

Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S. Kim PW, et al. Drug Saf. 2012 Jun 1;35(6):447-57. doi: 10.2165/11597460-000000000-00000. Drug Saf. 2012. PMID: 22612850 Review.

9

Using inpatient electronic medical records to study influenza for pandemic preparedness.

Fuller CC, Cosgrove A, Sands K, Miller KM, Poland RE, Rosen E, Sorbello A, Francis H, Orr R, Dutcher SK, Measer GT, Cocoros NM. Fuller CC, et al. Among authors: sorbello a. Influenza Other Respir Viruses. 2022 Mar;16(2):265-275. doi: 10.1111/irv.12921. Epub 2021 Oct 25. Influenza Other Respir Viruses. 2022. PMID: 34697904 Free PMC article.

10

Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Jones SC, Sorbello A, Boucher RM. Jones SC, et al. Among authors: sorbello a. Drug Saf. 2011 Oct 1;34(10):839-47. doi: 10.2165/11593110-000000000-00000. Drug Saf. 2011. PMID: 21879778 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page